|Participant Name||Employment||Consultant||Speaker's Bureau||Ownership/ Partnership/ Principal||Personal Research||Institutional, Organizational or Other Financial Benefit||Expert Witness|
|J. Jeffrey Carr||Wake Forest University School of Medicine, Division of Radiologic Sciences—Professor & Vice Chair of Clinical Research||None||None||None||None||None|
|Manuel D. Cerqueira||Cleveland Clinic Foundation—Chairman, Department of Molecular & Functional Imaging||None||None||None|
|Jennifer E. Cummings||University of Toledo—Associate Professor of Medicine||None||None||None||None|
|Pamela S. Douglas||Duke University Medical Center—Ursula Geller Professor of Research in Cardiovascular Diseases||None||None|
|Thomas C. Gerber||Mayo Clinic—Professor of Medicine, Radiology||None||None||None||None|
|Debabrata Mukherjee||Texas Tech University Health Sciences Center—Chief, Cardiovascular Medicine||None||None||None||None||None|
|Allen J. Taylor||Washington Hospital Center—Co-Director, Noninvasive Imaging||None||None||None||None|
This table represents all healthcare relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to http://www.cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx for definitions of disclosure categories or additional information about the ACCF Disclosure Policy for Writing Committees.
AHA indicates American Heart Association; AHRQ, Agency for Healthcare Research and Quality; DHHS, Department of Health and Human Services; DSMB, Data Safety Monitoring Board; FDA, Food and Drug Administration; NASCI, North American Society of Cardiovascular Imaging; NHLBI, National Heart, Lung, and Blood Institute; NIH, National Institutes of Health; SAIP, Society for Atherosclerosis Imaging and Prevention; and SCCT, Society of Cardiovascular Computed Tomography.